MIFAMURTIDE for Osteosarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 55 adverse event reports in the FDA FAERS database where MIFAMURTIDE was used for Osteosarcoma.
Most Reported Side Effects for MIFAMURTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Encephalopathy | 13 | 20.3% | 0 | 12 |
| Pyrexia | 12 | 18.8% | 1 | 9 |
| Confusional state | 11 | 17.2% | 0 | 9 |
| Leukoencephalopathy | 9 | 14.1% | 0 | 5 |
| Quadriplegia | 9 | 14.1% | 0 | 5 |
| Chills | 8 | 12.5% | 0 | 6 |
| Hemiparesis | 8 | 12.5% | 0 | 8 |
| Renal impairment | 8 | 12.5% | 0 | 8 |
| Allodynia | 7 | 10.9% | 0 | 0 |
| Aphasia | 7 | 10.9% | 0 | 5 |
| Drug clearance decreased | 7 | 10.9% | 0 | 7 |
| Drug level increased | 7 | 10.9% | 0 | 7 |
| Dysaesthesia | 7 | 10.9% | 0 | 0 |
| Headache | 6 | 9.4% | 0 | 6 |
| Malaise | 6 | 9.4% | 0 | 6 |
Other Indications for MIFAMURTIDE
Other Drugs Used for Osteosarcoma
METHOTREXATE (1,267)
DOXORUBICIN (1,135)
CISPLATIN (975)
IFOSFAMIDE (845)
ETOPOSIDE (531)
CARBOPLATIN (169)
CABOZANTINIB S-MALATE (116)
DOCETAXEL (99)
CYCLOPHOSPHAMIDE (92)
LENVATINIB (91)